Urinary tract infections in patients with type 2 diabetes mellitus: Review of prevalence, diagnosis, and management
On GLP-1 medications where transit time is already extended, the ceiling for comfortable fiber intake may be lower than for the general population
Anita Petruzzelli treats each woman as an individual and believe that all women deserve a customized and compassionate approach to health and wellness
In addition to their physical characteristics, pimples can also be classified based on their type
Free 15 Minute Health Consultation How do I stop my SIBO from coming back after taking antibiotics
Novo Nordisk (NVO): In 2023, Novo Nordisk announced the results from its SELECT trial that showed that semaglutide was associated with a 20% decreased risk of major adverse cardiac events comprised of cardiovascular death, nonfatal myocardial infarction (MI), and stroke compared with placebo in patients with overweight or obesity and established CVD but without diabetes